You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

Profile for Japan Patent: 6673915


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 6673915

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,335,452 Apr 5, 2037 Mallinckrodt Ireland TERLIVAZ terlipressin acetate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP6673915

Last updated: August 8, 2025


Introduction
Japan Patent JP6673915 pertains to a pharmaceutical invention that addresses specific medical or therapeutic needs through a novel compound, formulation, or method. Analyzing the scope and claims of JP6673915 reveals its strategic position within the pharmaceutical patent landscape, influences potential commercialization pathways, and underscores its robustness in patent protection. This report offers a comprehensive review suited for professionals evaluating the patent's enforceability, competitive landscape, and innovation scope.


Patent Overview and Context
JP6673915 was granted by the Japan Patent Office (JPO) and likely relates to a specific drug compound, a novel formulation, or a unique therapeutic method. Its issuance illustrates the patent examiner’s recognition of sufficient novelty, inventive step, and industrial applicability. Given the complex nature of pharmaceutical patents, the scope and claims critically define the legal exclusivity conferred.


Scope of the Patent
The scope of JP6673915 can be discerned primarily from the claims section. It encompasses the aspects that the patent holder seeks to protect, including:

  1. Compound Claims

    • The patent may claim a novel chemical entity, specifically defined by molecular structure, substituents, and stereochemistry.
    • Such claims generally include a compound formula, often exemplified with preferred embodiments and variations, such as salts, esters, or prodrug forms.
  2. Method Claims

    • Encompass specific synthesis routes, formulation methods, or therapeutic application procedures.
    • Might include innovative manufacturing processes that improve yield, purity, or stability.
  3. Use Claims

    • Could cover new therapeutic uses of the compound in particular diseases or conditions, thus extending protection beyond the compound itself.
  4. Dosage and Formulation Claims

    • Specify dosage forms, delivery systems (e.g., controlled-release), or combination therapies that enhance efficacy or patient compliance.
  5. Biological and Diagnostic Claims

    • In some cases, patents encompass biomarkers, diagnostic procedures, or bioanalytical methods associated with the compound.

Implication of Scope
Fundamentally, the scope hinges on how broadly or narrowly the claims are drafted. Broad claims covering a novel chemical class or therapeutic concept significantly enhance patent strength, constraining competitors from developing similar compounds or uses. Narrow claims, while easier to obtain, may be more vulnerable to design-around strategies.


Claims Analysis
A typical structure in JP6673915's claims might follow:

  • Independent Claims:

    • Covering the core compound or method, establishing the primary legal right.
    • For example, “A compound represented by the formula X, wherein R1, R2, and R3 are defined variables,” establishing the chemical boundaries.
  • Dependent Claims:

    • Adding specific limitations or embodiments, such as specific substitutions, stereochemistry, or combinations.
    • These serve to reinforce the patent’s defensibility against challenges and can be strategically valuable in infringement cases.

Strengths and Vulnerabilities

  • The strength of the patent depends on claim novelty, inventive step, and how well claims delineate the invention from prior art.
  • Overly broad claims might have faced restriction or rejection during prosecution, while overly narrow claims might leave room for workarounds.
  • The patent’s claims’ linkage to specific therapeutic uses or formulations can bolster its enforceability.

Patent Landscape in Japan and Globally

Japan's Pharmaceutical Patent Environment
Japan maintains a robust patent system aligned with the Patent Cooperation Treaty (PCT), enabling seamless international patent protection. The Japanese pharma patent landscape is characterized by:

  • High Standards for Patentability:

    • Stringent examination of novelty, inventive step, and industrial applicability.
    • Particularly rigorous for chemical and pharmaceutical patents due to the challenge in establishing inventive step given extensive prior art.
  • Evergreening and Patent Term Extensions:

    • Strategies such as secondary patents on formulations or new uses are commonplace.
  • Litigation and Enforcement:

    • A court system that actively enforces pharmaceutical patents, providing an effective mechanism for patent holders.

Global Context and Patent Families
JP6673915 might be part of an international patent family, with counterparts filed under the Patent Cooperation Treaty (PCT), United States, Europe, China, and other jurisdictions. Effective strategy involves leveraging these filings to gain broad protection, especially if the compound demonstrates global commercial potential.

Landscape Analysis

  • Prior Art References:

    • The patent likely cites earlier patents or scientific literature, such as compounds targeting specific receptors or enzymes, indicating the evolving landscape.
  • Competitor Activities:

    • Other companies may file similar patents on derivatives, formulations, or uses, creating a crowded patent space.
  • Legal and Regulatory Factors:

    • The expiration timeline, potential patent cliffs, and orphan drug status influence the patent’s overall strategy and value.

Legal Status and Future Outlook

  • The patent’s expiration date, approximately 20 years from the filing date (likely around 2030s), will influence its commercial lifespan.
  • The patent’s enforceability could be challenged via validity or non-infringement suits, especially if prior art emerges or patent claims are deemed overly broad.
  • Ongoing patent examinations or oppositions in Japan and elsewhere can impact future scope and enforcement.

Conclusion
JP6673915 embodies a strategic piece of pharmaceutical intellectual property, with its scope centered around a specific chemical compound, its methods of preparation, and therapeutic applications. Its claims are crafted to safeguard core innovations while attempting to balance breadth with legal robustness. The patent landscape suggests a competitive environment with overlapping patents and continuous innovation efforts that require vigilant monitoring to defend or challenge the patent rights effectively.


Key Takeaways

  • The scope of JP6673915 hinges on detailed chemical claims, method claims, and use cases that define its strength and market exclusivity.
  • Strategic claim drafting and comprehensive patent family filings are vital for maintaining competitive advantage.
  • Japan’s rigorous patent examination environment underscores the importance of high-quality, inventive claims.
  • The patent’s longevity and enforceability depend on ongoing legal vigilance and monitoring of prior art and potential infringement.
  • A global patent strategy enhances commercial potential and offers broader protection in key markets.

FAQs

1. What is the primary focus of JP6673915’s patent claims?
It primarily covers a novel chemical compound, its methods of synthesis, formulation, and specific therapeutic uses, providing comprehensive protection for core innovations.

2. How does JP6673915 compare to other patents in the same therapeutic area?
Its claims appear detailed, targeting specific molecular structures and applications, aligning with Japanese patent standards but requiring comparison with international counterparts for global robustness.

3. What strategies can competitors employ to circumvent JP6673915?
Designing structurally similar compounds outside the scope of claims, developing alternative synthesis methods, or targeting different therapeutic indications.

4. How does the patent landscape influence the commercial potential of JP6673915?
A crowded landscape may increase litigation risks but also underscores market interest; strategic patent filings can reinforce its position.

5. What is the significance of patent claims drafting in pharmaceutical patents?
Claims determine scope of protection. Well-drafted claims maximize exclusivity, reduce vulnerability, and support enforcement efforts.


References
[1] Japanese Patent JP6673915 (Official Patent Database)
[2] World Intellectual Property Organization Patent Landscape Reports, 2022
[3] Japan Patent Office Guidelines for Examination, 2023

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.